nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—PGR—meningioma	0.984	1	CbGaD
Medroxyprogesterone Acetate—Dydrogesterone—PGR—meningioma	0.00236	0.284	CrCbGaD
Medroxyprogesterone Acetate—Ethynodiol—PGR—meningioma	0.00194	0.234	CrCbGaD
Medroxyprogesterone Acetate—Megestrol acetate—PGR—meningioma	0.00142	0.171	CrCbGaD
Medroxyprogesterone Acetate—Drospirenone—PGR—meningioma	0.00124	0.149	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—PGR—meningioma	0.000883	0.106	CrCbGaD
Medroxyprogesterone Acetate—AR—FOXA1 transcription factor network—AP1B1—meningioma	0.000494	0.0624	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Validated nuclear estrogen receptor alpha network—AP1B1—meningioma	0.000481	0.0606	CbGpPWpGaD
Medroxyprogesterone Acetate—Progesterone—PGR—meningioma	0.000478	0.0574	CrCbGaD
Medroxyprogesterone Acetate—AR—Regulation of Androgen receptor activity—SMARCE1—meningioma	0.000426	0.0537	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—FOXA1 transcription factor network—AP1B1—meningioma	0.000381	0.048	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of Androgen receptor activity—SMARCE1—meningioma	0.000323	0.0408	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Nuclear Receptors—PGR—meningioma	0.000285	0.0359	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Validated nuclear estrogen receptor alpha network—AP1B1—meningioma	0.000282	0.0356	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—SMARCE1—meningioma	0.000281	0.0355	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Nuclear Receptor transcription pathway—PGR—meningioma	0.000225	0.0284	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Nuclear Receptors—PGR—meningioma	0.000219	0.0276	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptors—PGR—meningioma	0.000216	0.0272	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Nuclear signaling by ERBB4—PGR—meningioma	0.000215	0.0271	CbGpPWpGaD
Medroxyprogesterone Acetate—SHBG—Nongenotropic Androgen signaling—AKT1—meningioma	0.000208	0.0263	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Nuclear Receptor transcription pathway—PGR—meningioma	0.000173	0.0219	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptor transcription pathway—PGR—meningioma	0.000171	0.0215	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Notch-mediated HES/HEY network—HES1—meningioma	0.000164	0.0207	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Validated nuclear estrogen receptor alpha network—PGR—meningioma	0.000144	0.0182	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—HES1—meningioma	0.000105	0.0133	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ALAD—meningioma	9.33e-05	0.0118	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Corticotropin-releasing hormone—AKT1—meningioma	9.1e-05	0.0115	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CST3—meningioma	9.09e-05	0.0115	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—PLAU—meningioma	8.75e-05	0.011	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—SMO—meningioma	8.16e-05	0.0103	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—PLAU—meningioma	7.63e-05	0.00962	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—PLAU—meningioma	7.51e-05	0.00948	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PGR—meningioma	7.23e-05	0.00912	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—PDGFB—meningioma	7.21e-05	0.00909	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CST3—meningioma	7e-05	0.00883	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Nongenotropic Androgen signaling—AKT1—meningioma	6.45e-05	0.00814	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Estrogen signaling pathway—AKT1—meningioma	6.31e-05	0.00796	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—HES1—meningioma	6.29e-05	0.00793	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	6.28e-05	0.00792	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—TSHB—meningioma	6.01e-05	0.00758	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AP1B1—meningioma	5.65e-05	0.00712	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—meningioma	5.34e-05	0.00674	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—ERBB2—meningioma	4.99e-05	0.00629	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—ERBB2—meningioma	4.83e-05	0.00609	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—PTEN—meningioma	4.82e-05	0.00607	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—HES1—meningioma	4.77e-05	0.00602	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ALAD—meningioma	4.61e-05	0.00581	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—TP53—meningioma	4.53e-05	0.00571	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—PTEN—meningioma	4.49e-05	0.00567	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—PTEN—meningioma	4.43e-05	0.00558	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PDGFB—meningioma	4.23e-05	0.00533	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—PTEN—meningioma	4.12e-05	0.00519	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—AKT1—meningioma	3.97e-05	0.00501	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—PGR—meningioma	3.89e-05	0.0049	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Coregulation of Androgen receptor activity—AKT1—meningioma	3.75e-05	0.00473	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	3.7e-05	0.00466	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PTEN—meningioma	3.68e-05	0.00464	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CST3—meningioma	3.36e-05	0.00423	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—PTEN—meningioma	3.15e-05	0.00398	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—meningioma	3.07e-05	0.00387	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	3.07e-05	0.00387	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—meningioma	3.02e-05	0.00381	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—PGR—meningioma	2.99e-05	0.00377	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—meningioma	2.99e-05	0.00377	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—TSHB—meningioma	2.97e-05	0.00374	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—PGR—meningioma	2.95e-05	0.00372	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—ERBB2—meningioma	2.83e-05	0.00357	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—AKT1—meningioma	2.77e-05	0.0035	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—meningioma	2.66e-05	0.00336	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—AKT1—meningioma	2.65e-05	0.00334	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	2.61e-05	0.0033	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TSHB—meningioma	2.48e-05	0.00313	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—AKT1—meningioma	2.45e-05	0.00309	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—PTEN—meningioma	2.43e-05	0.00306	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PTEN—meningioma	2.42e-05	0.00305	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—AKT1—meningioma	2.37e-05	0.00299	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	2.36e-05	0.00298	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—meningioma	2.3e-05	0.00291	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—meningioma	2.27e-05	0.00286	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—meningioma	2.25e-05	0.00283	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—meningioma	2.15e-05	0.00271	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SMO—meningioma	2.11e-05	0.00266	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PGR—meningioma	2.02e-05	0.00255	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	2.01e-05	0.00254	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HES1—meningioma	1.98e-05	0.00249	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TSHB—meningioma	1.96e-05	0.00247	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PGR—meningioma	1.87e-05	0.00236	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—AKT1—meningioma	1.82e-05	0.00229	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—meningioma	1.82e-05	0.00229	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—meningioma	1.78e-05	0.00225	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PDGFB—meningioma	1.69e-05	0.00213	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SMO—meningioma	1.67e-05	0.0021	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—meningioma	1.66e-05	0.00209	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTEN—meningioma	1.64e-05	0.00207	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	1.51e-05	0.0019	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PGR—meningioma	1.44e-05	0.00182	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PGR—meningioma	1.42e-05	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—AKT1—meningioma	1.4e-05	0.00177	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—AKT1—meningioma	1.39e-05	0.00176	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HES1—meningioma	1.38e-05	0.00174	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	1.37e-05	0.00173	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALAD—meningioma	1.3e-05	0.00163	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PDGFB—meningioma	1.18e-05	0.00149	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	1.16e-05	0.00146	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TSHB—meningioma	1.15e-05	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—ERBB2—meningioma	1.13e-05	0.00143	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HES1—meningioma	1.09e-05	0.00138	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALAD—meningioma	1.05e-05	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SMO—meningioma	9.77e-06	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTEN—meningioma	9.66e-06	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—AKT1—meningioma	9.44e-06	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PGR—meningioma	9.37e-06	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PDGFB—meningioma	9.33e-06	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TSHB—meningioma	8.35e-06	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTEN—meningioma	8.09e-06	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ERBB2—meningioma	7.93e-06	0.001	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALAD—meningioma	6.95e-06	0.000877	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TSHB—meningioma	6.79e-06	0.000857	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTEN—meningioma	6.76e-06	0.000853	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HES1—meningioma	6.41e-06	0.000808	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ERBB2—meningioma	6.26e-06	0.000789	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKT1—meningioma	5.57e-06	0.000702	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PDGFB—meningioma	5.48e-06	0.000691	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTEN—meningioma	5.33e-06	0.000673	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—meningioma	5.11e-06	0.000644	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—AKT1—meningioma	4.73e-06	0.000596	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKT1—meningioma	4.66e-06	0.000588	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—meningioma	4.62e-06	0.000582	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TSHB—meningioma	4.48e-06	0.000565	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—meningioma	4.16e-06	0.000524	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKT1—meningioma	3.9e-06	0.000492	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ERBB2—meningioma	3.67e-06	0.000463	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—meningioma	3.64e-06	0.000459	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—AKT1—meningioma	3.6e-06	0.000454	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTEN—meningioma	3.13e-06	0.000395	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT1—meningioma	3.07e-06	0.000388	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—AKT1—meningioma	2.78e-06	0.00035	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—AKT1—meningioma	2.73e-06	0.000345	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTEN—meningioma	2.27e-06	0.000287	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—meningioma	2.14e-06	0.000269	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTEN—meningioma	1.85e-06	0.000233	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT1—meningioma	1.8e-06	0.000228	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKT1—meningioma	1.31e-06	0.000165	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTEN—meningioma	1.22e-06	0.000154	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKT1—meningioma	1.07e-06	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKT1—meningioma	7.03e-07	8.87e-05	CbGpPWpGaD
